The RIQAS Anti-SARS-CoV-2 EQA programme comprises IgG, IgM and total antibodies. This programme uniquely supports both qualitative and quantitative reporting.
- Liquid ready-to-use
- 100% human plasma provides a commutable sample matrix
- Monthly reporting – 2 samples per months
- Submit results and view reports online via RIQAS.Net
- Qualitative and Quantitative reporting options available
- Rapid report turnaround allows any necessary corrective actions to be made with minimal disruption
- Allows comparison of different methodologies
- Total Antibodies
Please note, product availability may vary country to country.